MSD - Equilis Prequenza 10 x 1 injector EU
Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
Composition:
Per dosis of 1ml: A/equine-2/Newmarket/2/93 50 AU and A/equine-2/South-Africa/4/03 50 AU subunits from equine influenza viruses
Indications:
Active immunisation of horses older than 6 months against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection.The onset of immunity is established at two weeks after basic vaccination. A priming response is maintained for up to 5 months after basic vaccination. The duration of immunity is up to 12 months after the first revaccination.
Dosage and administration:
Intramuscular injection of one dose (1 ml) per animal.
Vaccination schedule
Basic vaccination course
Foals should be vaccinated from the age of 6 months. Two vaccinations of one dose with a 4 week interval. The basic vaccination course results in immunity to equine influenza lasting at least 5 months.
Revaccination
The first revaccination (third dose) is given five months after the basic vaccination course. The revaccination results in immunity to equine influenza for at least 12 months. The second revaccination is given 12 months after the first revaccination.
Revaccination, at 12 month intervals of a suitable vaccine against equine influenza, such as Equilis® Prequenza or Equilis® Prequenza TE, both containing the strains A/equi 2/Newmarket-1/93 and A/equi 2/Newmarket-2/93, is recommended to maintain immunity levels against equine influenza.